13 February 2007

Novartis Does Open Genomics

It's happening, slowly:

Novartis, the Basel, Switzerland, drug giant, has helped uncover which of the 20,000 genes identified by the Human Genome Project are likely to be associated with diabetes. But rather than hoard this information, as drug firms have traditionally done, it is making it available for free on the World Wide Web.

"It will take the entire world to interpret these data," says Novartis research head Mark Fishman. "We figure we will benefit more by having a lot of companies look at these data than by holding it secret."

The data and more information is available from the Diabetics Genetics Initiative site at the Broad Institute. (Via Slashdot.)

No comments: